title: Reversible ototoxicity: a rare adverse reaction of liposomal amphotericin-B used for the treatment of antimony-resistant visceral leishmaniasis in an elderly male.
abstract: Amphotericin-B, a broad spectrum antifungal agent, has been known to cause adverse effects such as nephrotoxicity and infusion-related side effects such as fever, chills, rigor, and arthralgias. However, ototoxicity as an adverse effect of Amphotericin-B has not yet been reported in medical literature. We here report a case of a reversible form of ototoxicity induced by liposomal Amphotericin-B (L-AmB).
authors.affiliation: Assistant Professor, Dept. of Geriatric Medicine, All India Institute of Medical Sciences, New Delhi, India.
authors.forename: Pc
authors.initials: P
authors.lastname: Das
authors.affiliation: Junior Resident, Dept. of Geriatric Medicine, All India Institute of Medical Sciences, New Delhi, India.
authors.forename: Ramesh
authors.initials: R
authors.lastname: Kandel
authors.affiliation: Assistant Professor, Dept. of ENT, All India Institute of Medical Sciences, New Delhi, India.
authors.forename: Kapil
authors.initials: K
authors.lastname: Sikka
authors.affiliation: Professor and Head, Dept. of Geriatric Medicine, All India Institute of Medical Sciences, New Delhi, India.
authors.forename: Ab
authors.initials: A
authors.lastname: Dey
keywords: liposomal Amphotericin-B; ototoxicity
references.citation: Annu Rev Med. 2009;60:339-53
references.pmid: 18976115
references.citation: Otolaryngol Clin North Am. 1993 Oct;26(5):791-810
references.pmid: 8233489
references.citation: Drugs. 2013 Jun;73(9):919-34
references.pmid: 23729001
references.citation: Kidney Int. 2004 Feb;65(2):369-85
references.pmid: 14717907
references.citation: Drug Discov Today. 2005 Oct 1;10(19):1313-21
references.pmid: 16214676
references.citation: J Am Acad Audiol. 1992 May;3(3):166-75
references.pmid: 1581591
references.citation: Eur Rev Med Pharmacol Sci. 2011 Jun;15(6):601-36
references.pmid: 21796866
references.citation: Drug Saf. 2008;31(10):877-84
references.pmid: 18759511
references.citation: Int J Clin Pharmacol Ther. 2010 Aug;48(8):514-6
references.pmid: 20650042
references.citation: J Antimicrob Chemother. 1984 Jan;13 Suppl A:9-22
references.pmid: 6365884
references.citation: Rev Iberoam Micol. 2009 Dec 31;26(4):223-7
references.pmid: 19836985
references.citation: Auris Nasus Larynx. 1997 Apr;24(2):131-6
references.pmid: 9134134
references.citation: Acta Otolaryngol. 2014 May;134(5):448-54
references.pmid: 24702224
references.citation: Otolaryngol Clin North Am. 1993 Oct;26(5):829-44
references.pmid: 8233492
references.citation: Drug Saf. 1990 Mar-Apr;5(2):94-108
references.pmid: 2182052
references.citation: Otolaryngol Clin North Am. 1993 Oct;26(5):737-46
references.pmid: 8233486
references.citation: N Engl J Med. 2007 Jun 21;356(25):2571-81
references.pmid: 17582067